[Asia Economy Reporter Seulgina Jo]The Hong Kong government announced on the 1st that it will resume Pfizer-BioNTech COVID-19 vaccinations, which were temporarily suspended due to packaging defects, on the 5th.


According to Hong Kong public broadcaster RTHK, Patrick Nip, Secretary for the Civil Service of Hong Kong, confirmed this at a press conference on the same day.


He explained that following an investigation by the manufacturer and distributor regarding the packaging defects of the BioNTech vaccine, no issues related to the quality or safety of the vaccine were found.



In Hong Kong, out of a population of 7.5 million, 505,000 people have received the COVID-19 vaccine as of this day.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing